Efficacy of Cancer Support Programs: A Social Comparison Theory Analysis
Terminated
- Conditions
- Prostate Cancer
- Interventions
- Behavioral: Group MeetingsBehavioral: Questionnaire
- First Posted Date
- 2008-11-26
- Last Posted Date
- 2019-05-15
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 240
- Registration Number
- NCT00798187
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Fludarabine, Cyclophosphamide, and Rituximab - High Dose Frontline
Phase 2
Completed
- Conditions
- Chronic Lymphocytic Leukemia
- Interventions
- First Posted Date
- 2008-11-20
- Last Posted Date
- 2018-05-08
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 66
- Registration Number
- NCT00794820
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
A Pilot Study to Investigate the Effect of Cytotoxic Therapy and/or Radiotherapy on Cancer Related Sleep Disturbances in CLL and Breast Cancer Patients Experiencing Fatigue
- First Posted Date
- 2008-11-17
- Last Posted Date
- 2021-07-01
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 6
- Registration Number
- NCT00792077
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Parallel Phase I/II Trial of Decitabine and Peg-Interferon in Melanoma: Phase I Portion
- First Posted Date
- 2008-11-14
- Last Posted Date
- 2018-11-09
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 17
- Registration Number
- NCT00791271
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Bendamustine in Acute Leukemia and MDS
Phase 1
Terminated
- Conditions
- Acute Myeloid LeukemiaMyelodysplastic SyndromeAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia
- Interventions
- First Posted Date
- 2008-11-14
- Last Posted Date
- 2012-12-04
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 27
- Registration Number
- NCT00790855
- Locations
- 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States
Longitudinal Evaluation of Women Undergoing Pelvic Surgery for the Treatment of Gynecologic Cancer
Active, not recruiting
- Conditions
- Cervical CarcinomaVulvar CarcinomaEndometrial CarcinomaMalignant Female Reproductive System NeoplasmVaginal Carcinoma
- Interventions
- Other: Quality-of-Life AssessmentOther: Questionnaire Administration
- First Posted Date
- 2008-11-14
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 79
- Registration Number
- NCT00791635
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma
- First Posted Date
- 2008-11-13
- Last Posted Date
- 2011-12-08
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 1
- Registration Number
- NCT00790452
- Locations
- 🇺🇸
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer
Phase 2
Active, not recruiting
- Conditions
- Atypical Endometrial HyperplasiaStage IB Uterine Corpus Cancer AJCC v7Stage IA Uterine Corpus Cancer AJCC v7Stage II Uterine Corpus Cancer AJCC v7Stage I Uterine Corpus Cancer AJCC v7
- Interventions
- Other: Laboratory Biomarker AnalysisDevice: Levonorgestrel-Releasing Intrauterine SystemOther: Quality-of-Life Assessment
- First Posted Date
- 2008-11-11
- Last Posted Date
- 2025-03-05
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 69
- Registration Number
- NCT00788671
- Locations
- 🇺🇸
MD Anderson League City, Nassau Bay, Texas, United States
🇺🇸Lyndon Baines Johnson General Hospital, Houston, Texas, United States
🇺🇸M D Anderson Cancer Center, Houston, Texas, United States
Childhood Cancer Survivor Survey
Completed
- Conditions
- Cancer
- Interventions
- Other: Survey
- First Posted Date
- 2008-11-11
- Last Posted Date
- 2015-01-09
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 167
- Registration Number
- NCT00788476
- Locations
- 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States
SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma
Phase 1
Completed
- Conditions
- Lymphoma
- Interventions
- First Posted Date
- 2008-11-07
- Last Posted Date
- 2014-09-09
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 14
- Registration Number
- NCT00787527
- Locations
- 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States